Investment analysts at Ladenburg Thalmann started coverage on shares of Viveve Medical Inc (NASDAQ:VIVE) in a research note issued to investors on Tuesday. The firm set a “buy” rating on the stock.

Separately, Maxim Group reiterated a “buy” rating and set a $11.00 price objective (down previously from $16.00) on shares of Viveve Medical in a report on Tuesday, June 21st.

Shares of Viveve Medical (NASDAQ:VIVE) traded up 3.00% during midday trading on Tuesday, hitting $7.21. 78,771 shares of the stock traded hands. The firm’s 50 day moving average price is $7.58 and its 200 day moving average price is $6.60. The company’s market capitalization is $76.47 million. Viveve Medical has a 12-month low of $4.02 and a 12-month high of $10.50.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/viveve-medical-inc-vive-coverage-initiated-by-analysts-at-ladenburg-thalmann.html

Viveve Medical (NASDAQ:VIVE) last released its quarterly earnings data on Thursday, August 11th. The company reported ($0.66) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.48) by $0.18. The firm earned $1.56 million during the quarter, compared to analyst estimates of $1.33 million. Analysts expect that Viveve Medical will post ($2.06) EPS for the current year.

Viveve Medical Company Profile

Viveve Medical, Inc, formerly PLC Systems, Inc, designs, develops, manufactures and markets medical devices for the non-invasive treatment of vaginal laxity. The Company’s Viveve Treatment is a non-invasive solution for vaginal laxity that is performed in approximately 30 minutes, in a physician’s office.

5 Day Chart for NASDAQ:VIVE

Receive News & Ratings for Viveve Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.